Literature DB >> 12388652

Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents.

Alexander N Katchman1, Kelly A McGroary, Michael J Kilborn, Craig A Kornick, Paolo L Manfredi, Raymond L Woosley, Steven N Ebert.   

Abstract

We have evaluated the ability of various opioid agonists, including methadone, L-alpha-acetylmethadol (LAAM), fentanyl, meperidine, codeine, morphine, and buprenorphine, to block the cardiac human ether-a-go-go-related gene (HERG) K(+) current (I(HERG)) in human cells stably transfected with the HERG potassium channel gene. Our results show that LAAM, methadone, fentanyl, and buprenorphine were effective inhibitors of I(HERG), with IC(50) values in the 1 to 10 microM range. The other drugs tested were far less potent with respect to I(HERG) inhibition. Compared with the reported maximal plasma concentration (C(max)) after administration of therapeutic doses of these drugs, the ratio of IC(50)/C(max) was highest for codeine and morphine (>455 and >400, respectively), thereby indicating that these drugs have the widest margin of safety (of the compounds tested) with respect to blockade of I(HERG). In contrast, the lowest ratios of IC(50)/C(max) were observed for LAAM and methadone (2.2 and 2.7, respectively). Further investigation showed that methadone block of I(HERG) was rapid, with steady-state inhibition achieved within 1 s when applied at its IC(50) concentration (10 microM) for I(HERG) block. Results from "envelope of tails" tests suggest that the majority of block occurred when the channels were in the open and/or inactivated states, although approximately 10% of the available HERG K(+) channels were apparently blocked in a closed state. Similar results were obtained for LAAM. These results demonstrate that LAAM and methadone can block I(HERG) in transfected cells at clinically relevant concentrations, thereby providing a plausible mechanism for the adverse cardiac effects observed in some patients receiving LAAM or methadone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388652     DOI: 10.1124/jpet.102.038240

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  64 in total

1.  Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients.

Authors:  Billy Huh; Chan-Hong Park
Journal:  Korean J Anesthesiol       Date:  2010-04-28

2.  Punishment induces risky decision-making in methadone-maintained opiate users but not in heroin users or healthy volunteers.

Authors:  Karen D Ersche; Jonathan P Roiser; Luke Clark; Mervyn London; Trevor W Robbins; Barbara J Sahakian
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

Review 3.  Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence.

Authors:  Alexander Elkader; Beth Sproule
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

4.  Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature.

Authors:  David W Abramson; Davin K Quinn; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 5.  Role of active metabolites in the use of opioids.

Authors:  Janet K Coller; Lona L Christrup; Andrew A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  2008-10-29       Impact factor: 2.953

6.  Case files of the Drexel University Medical Toxicology Fellowship: methadone-induced QTc prolongation.

Authors:  Stella C Wong; James R Roberts
Journal:  J Med Toxicol       Date:  2007-12

7.  Relationship between methadone and EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) in urine samples from Norwegian prisons.

Authors:  Jean-Paul Bernard; Mimi Stokke Opdal; Ritva Karinen; Jørg Mørland; Hassan Z Khiabani
Journal:  Eur J Clin Pharmacol       Date:  2007-06-19       Impact factor: 2.953

8.  The opioid oxycodone use-dependently inhibits the cardiac sodium channel NaV 1.5.

Authors:  Jannis E Meents; Krisztina Juhasz; Sonja Stölzle-Feix; Vera Peuckmann-Post; Roman Rolke; Angelika Lampert
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

9.  Effects of Methadone on Corrected Q-T Interval Prolongation in Critically Ill Children.

Authors:  Travis S Heath; Rachel G Greenberg; Susan R Hupp; David A Turner; Christoph P Hornik; Kanecia O Zimmerman
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr

Review 10.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.